Want to see HK:1358 full AI Analyst Report?
1358 Stock Chart & Stats
HK$1.30
HK$0.02(2.06%)
At close: 4:00 PM EST
HK$1.30
HK$0.02(2.06%)
Day’s Range― - ―
52-Week RangeHK$0.88 - HK$1.63
Previous CloseN/A
Volume329.00K
Average Volume (3M)553.20K
Market Cap
HK$1.30B
Enterprise ValueHK$506.82
Total Cash (Recent Filing)HK$1.83B
Total Debt (Recent Filing)HK$21.03M
Price to Earnings (P/E)26.2
Beta0.28
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.27%
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,433,241,100
10 Day Avg. Volume359,000
30 Day Avg. Volume553,200
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.44
Price to Sales (P/S)2.13
P/FCF Ratio12.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageThe extremely low debt burden provides substantial financial resilience and limits interest-related pressure on earnings. A conservative balance sheet also preserves flexibility to fund operations, withstand weaker periods, and pursue opportunities without relying heavily on external financing.
Positive Cash GenerationPositive operating and free cash flow demonstrate that the business is generating cash internally despite recent volatility. This supports ongoing operations, capital needs, and shareholder returns, while reducing dependence on borrowing to sustain the company over coming quarters.
Established Historical GrowthStrong growth across FY2022–FY2024 and consistently healthy gross margins indicate that the business has previously converted demand into profitable expansion. That operating history provides evidence of an established commercial model and a potential base for recovery after the latest slowdown.
Bears Say
Recent Revenue DeclineThe latest revenue contraction signals weaker demand or execution than in the preceding growth period. If sustained, lower sales would reduce operating leverage, constrain investment capacity, and make it harder for the company to rebuild earnings momentum over the next several quarters.
Material Margin CompressionThe sharp reduction in both net and EBITDA margins indicates that profitability has weakened beyond the effect of slower revenue alone. Persistent compression would reduce earnings quality, limit internally funded growth, and make future results more sensitive to changes in sales volume.
Volatile Free Cash FlowAlthough cash generation remains positive, repeated year-over-year weakening in free cash flow points to inconsistent conversion of operations into available cash. This volatility can complicate capital planning and reduce confidence in the durability of funding for investment or distributions.
PW Medtech Group Ltd. News
1358 FAQ
What was PW Medtech Group Ltd.’s price range in the past 12 months?
PW Medtech Group Ltd. lowest stock price was HK$0.88 and its highest was HK$1.63 in the past 12 months.
What is PW Medtech Group Ltd.’s market cap?
PW Medtech Group Ltd.’s market cap is HK$1.30B.
When is PW Medtech Group Ltd.’s upcoming earnings report date?
PW Medtech Group Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 190 days.
How were PW Medtech Group Ltd.’s earnings last quarter?
PW Medtech Group Ltd. released its earnings results on Aug 28, 2026. The company reported HK$0.012 earnings per share for the quarter.
Is PW Medtech Group Ltd. overvalued?
According to Wall Street analysts PW Medtech Group Ltd.’s price is currently Overvalued.
Does PW Medtech Group Ltd. pay dividends?
PW Medtech Group Ltd. pays a Semiannually dividend of HK$0.011 which represents an annual dividend yield of 7.27%. See more information on PW Medtech Group Ltd. dividends here
What is PW Medtech Group Ltd.’s EPS estimate?
PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PW Medtech Group Ltd. have?
PW Medtech Group Ltd. has 1,433,241,100 shares outstanding.
What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?
PW Medtech Group Ltd. reported an EPS of HK$0.012 in its last earnings report. Following the earnings report the stock price went up 1.111%.
Which hedge fund is a major shareholder of PW Medtech Group Ltd.?
Currently, no hedge funds are holding shares in HK:1358
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PW Medtech Group Ltd.
Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medical consumables, including various types of infusion sets such as non-PVC, precision filter, and light-resistant models, alongside intravenous cannula products and insulin needles and pens. Beyond its core medical device activities, the group also provides property management services. Established in 1997, the company, previously known as Pyholding Limited, maintains its corporate headquarters in Beijing, China.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―